Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis

Annals of Neurology

Volumn 41, Issue 2, 1997, Pages 210-221

  Cudkowicz, M E ^a   McKenna Yasek, D ^a   Sapp, P E ^a,b   Chin, W ^a,b   Geller, B ^a,b   Hayden, D L ^a   Schoenfeld, D A ^a   Hosler, B A ^a   Horvitz, H R ^b   Brown, R H ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE; COPPER ZINC SUPEROXIDE DISMUTASE; VALINE;

ADULT; AGED; AMINO ACID SUBSTITUTION; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL FEATURE; FEMALE; GENE MUTATION; GENETIC EPIDEMIOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; SURVIVAL;

ADULT; AGE OF ONSET; AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; HUMANS; MALE; MIDDLE AGED; MUTATION; SUPEROXIDE DISMUTASE;

EID: 0031057003     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.410410212     Document Type: Article

References (57)

1. Adams RD, Victor M. Degenerative diseases of the nervous system. In: Adams RD, Victor M, eds. Principles of neurology. New York: McGrall-Hill, 1989:953-956
2. Horton WA, Eldridge R, Brody JA. Familial motor neuron disease: evidence for at least three different types. Neurology 1976:26:460-465
3. Emard JF, Thouez JP, Gauvreau D, Neurodegenerative disease and risk factors: a literature review. Soc Sci Med 1995;40:847-858
4. Kurtzke JF, Kurland LT. The epidemiology of neurologic disease. In: Joynt R, ed. Clinical neurology. Philadelphia: JB Lippincott, 1983:1-43
5. Annegers JF, Appel S, Lee JF, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1988:48:589-593
6. Forsgren L, Almay GL, Holmgren G, Wall S. Epidemiology of motor neuron disease in northern Sweden. Acta Neurol Scand 1983:68:20-29
7. Mulder DW, Kurland LT, Offord KP, Beard CM. Familial adult motor neuron disease: amyotrophic lateral sclerosis. Neurology 1986;36:511-517
8. Rosen DR, Siddique T, Patterson D, et al. Mutations in Cu/Zn Superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 1993;362:59-62
9. Swerts L, VanDenBerg P. Sclerose laterale amyotrophique familiale. J Genet 1976;24:147-155
10. Kurtzke JF. Risk factors in amyotrophic lateral sclerosis. Adv Neurol 1991:56:245-270
11. Munsat TL. Adult motor neuron disease. In: Rowland LP, ed. Merritt's textbook of neurology. Philadelphia: Lea & Febiger, 1989:682-687
12. Sienko DG, Davis JP, Taylor JA, Brooks B. Amyotrophic lateral sclerosis: a case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol 1990;47:38-41
13. Appel V, Stewart SS, Smith G, Appel SH. A rating scale for amyotrophic lateral sclerosis: description and preliminary experience. Ann Neurol 1987:22:328-333
14. Munsat TL, Andres PL, Finison L, et al. The natural history of motorneuron loss in ALS. Neurology 1988;38:452-458
15. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995;118:707-719
16. Norris F, Shepherd R, Denys E, et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. J Neurol Sci 1993;118:48-55
17. Jablecki CK, Berry C, Leach J. Survival prediction in amyotrophic lateral sclerosis. Muscle Nerve 1989;12:833-841
18. Gubbay SS, Kahana E, Zilber N, et al. Amyotrophic lateral sclerosis: a study of its presentation and prognosis. J Neurol 1985;232:295-300
19. Eisen A, Schulzer M, MacNeil M, et al. Duration of amyotrophic lateral sclerosis is age dependent. Muscle Nerve 1993:16:27-32
20. Louverse ES, Bossuyt PMM, Weverling GJ, Jong JV. Mortality risk stratification in amyotrophic lateral sclerosis. J Neurol Sci 1995;129:27
21. Strong MJ, Hudson AJ, Alvord WG. Familial amyotrophic lateral sclerosis, 1850-1989: a statistical analysis of the world literature. Can J Neurol Sci 1991;18:45-58
22. Kurland LT, Mulder DW. Epidemiologic investigations of amyotrophic lateral sclerosis. Neurology 1955;5:249-268
23. Rosen DR, Brown RH Jr. Dinucleotide repeat polymorphism in the HOX4E locus. Hum Mol Genet 1993;2:617
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Am Stat Assoc J 1958:53:457-481
25. Lee ET. Statistical methods for survival data analysis. Belmont, MA: Wadsworth, 1980
26. Peto R, Pike MC, Armitage P, et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977;35:1-39
27. Cox DR. Regression models and life-tables. J R Stat Soc B 1972;34:187-202
28. Lawless JE. Statistical models and methods for lifetime data. New York: Wiley, 1982
29. Hollander M, Wolfe DA. Nonparametric statistical methods. New York: Wiley, 1973:73
30. Hentati A, Bejaoui K, Pericak-Vance MA, et al. Linkage of recessive familial amyotrophic lateral sclerosis to chromosome 2q33-35. Nat Genet 1994;7:425-428
31. Strittmatter WJ, Saunders AM, Schmechel D, et al. Apolipoprotein E: high avidity binding to β amyloid and increased frequence of type 4 allele in late-onset familial Alzheimer disease. Proc Natl Acad Sci USA 1993;90:1977-1981
32. Mui S, Rebeck GW, McKenna-Yasek D, et al. Apolipoprotein E ε4 allele is not associated with earlier age at onset in amyotrophic lateral sclerosis. Ann Neurol 1995;38:460-463
33. Ammar A, Enayat ZE, Bakker MC, et al. Early reports: association of apolipoprotein E epsilon 4 allele with bulbar-onset motor neuron disease. Lancet 1996;347:159-160
34. Deng H-X, Hentati A, Tainer JA, et al. Amyotrophic lateral sclerosis and structural defects in Cu,Zn Superoxide dismutase. Science 1993;261:1047-1051
35. Osier W. Heredity in progressive muscular atrophy as illustrated in Farr family of Vermont. Arch Med 1880;4:316-320
36. Robberecht W, Sapp P, Viaene MK, et al. Cu/Zn Superoxide dismutase activity in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1994;62:384-387
37. Takahashi H, Makifuchi T, Nakano R, et al. Familial amyotrophic lateral sclerosis with a mutation in the Cu/Zn Superoxide dismutase gene. Acta Neuropathol (Berl) 1994;88:185-188
38. Hirano M, Fujii J, Nagai Y, et al. A new variant Cu/Zn superoxide dismutase (Val 7 to Glu) deduced from lymphocyte mRNA sequences from Japanese patients with familial amyotrophic lateral sclerosis. Biochem Biophys Res Commun 1994;204:572-577
39. Rainero I, Pinessi L, Tsuda T, et al. SOD1 missense mutation in an Italian family with ALS. Neurology 1994;44:347-349
40. Aoki M, Ogasawara M, Matsubara Y, et al. Familial amyotrophic lateral sclerosis (ALS) in Japan associated with H46R mutation in Cu/Zn Superoxide dismutase gene: a possible new subtype of familial ALS. J Neurol Sci 1994;126:77-83
41. Aoki M, Abe K, Houi K, et al. Variance of age at onset in a Japanese family with amyotrophic lateral sclerosis associated with a novel Cu/Zn Superoxide dismutase mutation. Ann Neurol 1995;37:676-679
42. Calder VL, Domigan NM, George PM, et al. Superoxide dismutase (glu100gly) in a family with inherited motor neuron disease: detection of mutant Superoxide dismutase activity and the presence of heterodimers. Neurosci Lett 1995:189:143-146
43. Kawamata J, Hasegawa H, Shimorhama S, et al. Leu106 to Val (CTC→GTC) mutation of Superoxide dismutase-1 gene in patients with familial amyotrophic lateral sclerosis in Japan. Lancet 1994;343:1501
44. Orrell RW, King AW, Hilton DA. Familial amyotrophic lateral sclerosis with a point mutation of SOD 1: intrafamilial heterogeneity of disease duration associated with neurofibrillary tangles. J Neurol Neurosurg Psychiatry 1995;59:266-270
45. Suthers G, Laing N, Wilton S, et al. "Sporadic" motorneuron disease due to familial SOD1 mutation with low penetrance. Lancet 1994;344:1773
46. Ikeda M, Abe K, Ogasawara M, et al. A novel point mutation in the Cu/Zn Superoxide dismutase gene in a patient with familial amyotrophic lateral sclerosis. Hum Mol Genet 1995;4:491-492
47. Gurney ME, Cutting FB, Zhai P, et al. Benefit of vitamin E, riluzole and gabapentin in a transgenic model of familial ALS. Ann Neurol 1996;39:147-157
48. Bensimon G, Lacomblez L, Meininger V, et al. A controlled trial of riluzole in amyotrophic lateral sclerosis. N Engl J Med 1994;330:585-591
49. Brown RH. Superoxide dismutase in familial amyotrophic lateral sclerosis: models for gain of function. Curr Opin Neurobiol 1995;5:841-846
50. Bowling AC, Schulz JB, Brown RH Jr, Beal MF. Superoxide dismutase activity, oxidative damage and mitochondrial energy metabolism in familial and sporadic amyotrophic lateral sclerosis. J Neurochem 1993;61:2322-2325
51. Siddique TS, Figlewicz DA, Pericak-Vance MA, et al. Linkage of a gene causing familial amyotrophic lateral sclerosis to chromosome 21 and evidence of genetic-locus heterogeneity. N Engl J Med 1991;324:1381-1384
52. Cleveland DW, Laing N, Hurse PV, Brown RH. Toxic mutants in Charcot's sclerosis. Nature 1995;378:342-343
53. Borchelt DR, Lee MK, Slunt HS, et al. Superoxide dismutase 1 with mutations linked to familial amyotrophic lateral sclerosis possesses significant activity. Proc Natl Acad Sci USA 1994;91:8292-8296
54. Chio A, Brignolio F, Meinere D, Schiffer D. Phenotypic and genotypic heterogeneity of dominantly inherited amyotrophic lateral sclerosis. Acta Neurol Scand 1986;75:277-282
55. Orrell RW, King AW, deBelleroche JS. Parental influence on inheritance of familial amyotrophic lateral sclerosis. Lancet 1995;345:391-392
56. Leone M. Parental sex effect in familial amyotrophic lateral sclerosis. Neurology 1991;41:1292-1294
57. Orrell RW, de Belleroche JS, Marklund S, et al. A novel SOD mutant and ALS. Nature 1995;374:504-505